This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Sleep, Fatigue, and Dexamethosone in Children With Leukemia

This study has been completed.
Information provided by:
National Institute of Nursing Research (NINR) Identifier:
First received: January 2, 2004
Last updated: August 14, 2008
Last verified: August 2008
The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue.

Condition Intervention Phase
Leukemia Drug: Dexamethosone Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Sleep, Fatigue, and Dexamethosone in Childhood Cancer

Resource links provided by NLM:

Further study details as provided by National Institute of Nursing Research (NINR):

Primary Outcome Measures:
  • Fatigue and sleep quality changes [ Time Frame: 10 days ]

Secondary Outcome Measures:
  • Pharmacogenetics with dextamethasone use [ Time Frame: 5 days ]
  • Pharmacokinetics with dextamethasone use [ Time Frame: 5 days ]

Estimated Enrollment: 134
Study Start Date: September 2000
Study Completion Date: September 2006
Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Study Cycle Drug: Dexamethosone
10 day study cycle: 5 day observation pre-steroid,5 day observation post-steroid
Other Name: Mestinon

Detailed Description:
Approximately 134 children and adolescents will be enrolled. All children and adolescents will wear a wrist actigraph for two consecutive 5-day study periods. Children and adolescents will have blood drawn 2 times on Day 1 when they are on dexamethosone. Their parents will complete a sleep diary and fatigue questionnaire by telephone on Days 2 and 5 of both study periods.

Ages Eligible for Study:   5 Years to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Children and adolescents with Leukemia, both genders
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00075101

United States, Tennessee
St. Jude Children Research Hospital
Memphis, Tennessee, United States, 38105
Sponsors and Collaborators
National Institute of Nursing Research (NINR)
Principal Investigator: Pamela S Hinds, PhD St. Jude Children's Research Hospital
  More Information

Responsible Party: Pamela S. Hinds, St. Jude Children's Research Hospital Identifier: NCT00075101     History of Changes
Other Study ID Numbers: 1R01NR007610-01 ( U.S. NIH Grant/Contract )
Study First Received: January 2, 2004
Last Updated: August 14, 2008

Keywords provided by National Institute of Nursing Research (NINR):
Drug Adverse Effect
Pediatric Cancer

Additional relevant MeSH terms:
Neoplasms by Histologic Type
Signs and Symptoms processed this record on August 23, 2017